The difference in blood pressure readings between arms and survival: primary care cohort study by Clark, CE et al.
The difference in blood pressure readings between
arms and survival: primary care cohort study
OPEN ACCESS
Christopher E Clark clinical academic fellow 1, Rod S Taylor professor in health services research,
medical statistician 1, Angela C Shore professor of cardiovascular science 2, John L Campbell
professor of general practice and primary care 1
1Primary Care Research Group, Institute of Health Services Research, Peninsula College of Medicine and Dentistry, University of Exeter, Devon
EX1 2LU, UK; 2Institute of Biomedical and Clinical Science, Peninsula College of Medicine and Dentistry, and Peninsula NIHR Clinical Research
Facility, University of Exeter, Devon, UK
Abstract
Objective To determine whether a difference in systolic blood pressure
readings between arms can predict a reduced event free survival after
10 years.
Design Cohort study.
Setting Rural general practice in Devon, United Kingdom.
Participants 230 people receiving treatment for hypertension in primary
care.
Intervention Bilateral blood pressure measurements recorded at three
successive surgery attendances.
Main outcome measures Cardiovascular events and deaths from all
causes during a median follow-up of 9.8 years.
Results At recruitment 24% (55/230) of participants had amean interarm
difference in systolic blood pressure of 10 mm Hg or more and 9%
(21/230) of 15 mm Hg or more; these differences were associated with
an increased risk of all cause mortality (adjusted hazard ratio 3.6, 95%
confidence interval 2.0 to 6.5 and 3.1, 1.6 to 6.0, respectively). The risk
of death was also increased in 183 participants without pre-existing
cardiovascular disease with an interarm difference in systolic blood
pressure of 10 mm Hg or more or 15 mm Hg or more (2.6, 1.4 to 4.8
and 2.7, 1.3 to 5.4). An interarm difference in diastolic blood pressure
of 10 mm Hg or more was weakly associated with an increased risk of
cardiovascular events or death.
Conclusions Differences in systolic blood pressure between arms can
predict an increased risk of cardiovascular events and all cause mortality
over 10 years in people with hypertension. This difference could be a
valuable indicator of increased cardiovascular risk. Bilateral blood
pressure measurements should become a routine part of cardiovascular
assessment in primary care.
Introduction
A difference in blood pressure readings between arms can be
observed in various general populations,1 2 healthy women
during the antenatal period,3 4 and populations with an increased
risk of cardiovascular disease, such as people with hypertension,5
diabetes,6 7 chronic renal disease,8 or peripheral vascular disease.9
The presence of a difference between arm measurements has
been implicated in a delayed diagnosis of hypertension10 and is
associated with a higher prevalence of poor control in
hypertension,9 as failure to standardise measurement to the arm
with the highest reading can mislead decisions about
management. Current guidelines recognise the need to check
blood pressure in both arms11 12 but this practice has not been
followed by many clinicians,13 14 including general practitioners
in the United Kingdom,15 and continues to be undertaken
selectively in primary care settings.16 This poor uptake may in
part result from a lack of clearly presented supporting evidence
for this intervention that is relevant to primary care
practitioners.17
The new clinical guideline for hypertension from the National
Institute for Health and clinical Excellence considers an interarm
difference of less than 10 mm Hg to be normal and attributes a
difference of more than 20 mm Hg to underlying vascular
disease.18 An evidence review for interarm differences in blood
pressure was outside the remit of this update; however, it did
not consider the group with an interarm difference in systolic
blood pressure of 10-20mmHg, despite our previous systematic
review suggesting that this group represents 15% of the
population with hypertension.1
Our previous work has suggested that an interarm difference in
blood pressure is an independent predictor of reduced event free
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survival.5 19 Others have also shown an association with
increased mortality in people at higher risk of vascular disease,8 9
and the need for further studies carried out in primary care
settings has been highlighted.9 We further analysed an
established primary care cohort to determine to what extent the
difference in survival observed at five years persists at 10 years.5
Methods
The Mid Devon Medical Practice operates three separate
surgeries in a rural area. This study was carried out in the main
surgery (list size 1900). Eligible participants were those
registered with the author (CEC) and receiving treatment for
hypertension. Hypertension was defined by the then current
guidelines of the British Hypertension Society (≥160/100 mm
Hg or ≥140/90 mm Hg in the presence of target organ damage,
diabetes, or coronary heart disease risk score ≥15%).20 We
excluded participants on the basis of anatomical criteria (loss,
previous injury, surgery above wrist level, or paralysis of one
arm) or for practical reasons—that is, the inability or
unwillingness to regularly attend the surgery for review.
Measurements
At recruitment one investigator (CEC) measured blood pressure
using a standard mercury sphygmomanometer (Accoson; AC
Cossor, Harlow, Essex), which was calibrated every six months.
Standard or large cuffs were used as appropriate. Pairs of blood
pressure readings were collected sequentially after the participant
had been seated for five minutes; measurement was taken in the
arm first presented without prompting, and the cuff was then
swapped to the other arm and another measurement taken. The
arm was supported during each measurement. We obtained
single pairs of measurements at the first and subsequent two
visits and recruitment ran from 9 November 1999 to 17 June
2002. Return visits were planned every six months if blood
pressure was controlled, or at shorter intervals if treatment for
high blood pressure was being adjusted. We averaged the three
pairs of readings to obtain a mean systolic and diastolic blood
pressure for each arm to derive the mean interarm difference.
After the first visit we recorded the participant’s medical history
and characteristics (age, sex, smoking status, body mass index,
glucose level, total cholesterol level, creatinine level,
pre-treatment blood pressure, years since diagnosis of
hypertension, evidence of left ventricular hypertrophy on
electrocardiogram, and Framingham risk score calculated from
pre-treatment values extracted from patient records). If such
data were missing we undertook the necessary investigations.
Drugs were adjusted to achieve optimal blood pressure control
according to guidelines, but we did not include use of drugs in
the dataset.20 We prospectively collected data on events until
26 April 2011. Events were defined as death (cardiovascular or
all cause using death certification data augmented where
available by post mortem findings) or non-fatal cerebrovascular
events, and cardiovascular events (myocardial infarction or a
new diagnosis of angina), confirmed after referral to secondary
care.
Data analysis
We entered anonymised data on an Excel spreadsheet and used
SPSS Predictive Analytics Software Statistics v18.0.0 and Stata
v11.1 for analysis. Left ventricular hypertrophy was diagnosed
by electrocardiography at recruitment using the Perugia scoring
system,21 and we calculated scores for the risk of coronary heart
disease at 10 years from the Framingham equation.22 We
compared the participant’s characteristics at entry to the cohorts
using t or χ2 tests between groups according to predefined cut-off
points of interarm differences that have been used in the
literature and in our previous report—namely, 10 mm Hg or
more and 15 mm Hg or more differences in systolic blood
pressure and 10 mm Hg or more differences in diastolic blood
pressure. At each of these cut-off points we used Kaplan-Meier
survival plots to compare the time to death (all cause and
cardiovascular), combined non-fatal cardiovascular and
cerebrovascular events, and death or non-fatal events. We used
a Cox’s proportional hazards regression model to calculate the
unadjusted hazard ratios for these outcomes, fitting interarm
difference as either a continuous variable or using the defined
cut-off points. A multivariable Cox regression model was used
to derive adjusted hazard ratios, which included the Framingham
risk score (model 1) and, in addition, included mean blood
pressure (systolic for analyses of systolic interarm difference,
and diastolic for analyses of diastolic interarm difference,
calculated as the mean of three pairs (n=6) of blood pressure
measurements at recruitment), presence of diabetes, and
pre-existing cardiovascular or peripheral vascular disease on
entry to the cohort (model 2). Regardless of their statistical
effect we included these variables in the model for their
relevance on clinical grounds. To assess the specific contribution
of interarm differences in blood pressure, we used the likelihood
ratio test to assess the reduction in goodness of fit arising as the
result of omitting the interarm difference term from each of the
adjusted models. A predefined secondary analysis was
undertaken in the subgroup of participants without previous
cardiovascular disease at entry to the cohort. We assessed
proportionality of hazards over time by plotting
−ln(−ln(survival)) versus ln(analysis time), and tested this using
Schoenfeld residuals.23 24 (Also see web extra on bmj.com.) We
found no major violations of the proportional hazards
assumption. The competing risk of death was accounted for by
censoring at the date of death. In mortality outcomemodels, we
considered any previous non-fatal events to be uninformative.
Results
Of 273 patients (14.3% of surgery list) eligible for inclusion,
247 (90%) were recruited by June 2002 and 230 (84%) with
complete data were analysed (fig 1⇓). No participants were lost
to follow-up. Participants not included in the analysis were
significantly older but did not differ in any other respect from
the cohort analysed (table 1⇓). The median time to collection
of all three sets of readings was four months (interquartile range
2-12 months). At recruitment, 55 (24%) participants had a mean
interarm difference in systolic blood pressure of 10 mm Hg or
more and 21 (9%) a difference of 15 mm Hg or more (fig 2⇓);
14 (6%) participants had an interarm difference in diastolic
blood pressure of 10 mm Hg or more. The mean difference in
systolic blood pressure was 1.5mmHg (95% confidence interval
0.4 to 2.6) higher in the right arm and in diastolic blood pressure
was 1.7 mm Hg (1.1 to 2.3) higher in the left arm.
The median time to final analysis or to a fatal event was 9.8
years (interquartile range 0.4-11.4 years). During the study
period, 52 cardiovascular and 27 cerebrovascular events
occurred in 76 participants. Fifty nine participants died and a
total of 100 (44%) participants had an event or died.
All case analysis
There were no differences in the baseline characteristics of
participants above and below an interarm difference in systolic
blood pressure of 10 mm Hg or more or 15 mm Hg or more or
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an interarm difference in diastolic blood pressure of 10 mm Hg
or more (table 2⇓).
In both unadjusted and adjusted analyses an interarm difference
in systolic blood pressure of 10 mmHg or more and 15 mmHg
or more were both associated with increases in the hazard of
cardiovascular events, cardiovascular mortality, all cause
mortality, and combined non-fatal events or all cause mortality.
Hazard ratios for all cause mortality after full adjustment were
3.6 (95% confidence interval 2.0 to 6.5) for interarm differences
in systolic blood pressure of 10 mm Hg or more (fig 3⇓) and
3.1 (1.6 to 6.0) for differences of 15 mmHg or more (table 3⇓).
This corresponded to a 5-6% increase in the hazard of outcomes
for each 1 mm Hg increment in interarm difference for systolic
blood pressure (table 4⇓). An interarm difference in diastolic
blood pressure of 10 mm Hg or more was associated, with less
precision, with increases in the hazard of cardiovascular events
and combined non-fatal events or all cause mortality in both
unadjusted and adjusted analyses: adjusted hazard ratios 3.8
(95% confidence interval 1.8 to 8.6) and 3.3 (1.6 to 6.8),
respectively. After adjustment this corresponded to a 9%
increase in hazard of any fatal or non-fatal event for each 1 mm
Hg increment in interarm difference for diastolic blood pressure.
Across all models for systolic blood pressure the likelihood
ratio test showed a significant reduction in goodness of fit on
removal of interarm difference, with the exception of
cardiovascular mortality associated with a difference of 15 mm
Hg or more, indicating that inclusion of interarm differences in
systolic blood pressure consistently improved the predictability
of models. This was also shown for an interarm difference in
diastolic blood pressure of 10 mm Hg or more with non fatal
events and combined events and deaths (tables 3 and 4).
Analyses without pre-existing cardiovascular
disease
At recruitment 183 participants had no pre-existing
cardiovascular disease; 28% (n=51) had an interarm difference
in systolic blood pressure of 10mmHg or more and 11% (n=20)
a difference of 15 mm Hg or more, and 6% (n=11) had an
interarm difference in diastolic blood pressure of 10 mm Hg or
more. In this subgroup, sensitivity analyses of predefined levels
of interarm differences in both systolic and diastolic blood
pressures were examined for differences in mortality and event
free survival. The findings of unadjusted and adjusted Cox
regression analyses were consistent with the full case analysis,
showing increases in the hazards of cardiovascular events,
cardiovascular mortality, all cause mortality, and combined
events or deaths in both unadjusted and adjusted analyses for
interarm differences in systolic blood pressure of 10 mm Hg or
more or 15 mmHg or more; hazard ratios for all cause mortality
were 2.6 (95% confidence interval 1.4 to 4.8; fig 4⇓) and 2.7
(1.3 to 5.4). An interarm difference in diastolic blood pressure
of 10 mm Hg or more was associated with an increased hazard
of cardiovascular events, and combined non-fatal events or all
cause mortality after adjustment: hazard ratios 3.2 (1.3 to 8.1)
and 2.4 (1.0 to 5.9); table 5⇓. When interarm difference was
analysed as a continuous variable, the hazard of all outcomes
increased by a consistent 5% for each 1 mm Hg increment in
interarm difference in systolic blood pressure after adjustment.
In the continuous model the hazard ratios for an interarm
difference in diastolic blood pressure were no longer significant
(table 4). Associated reductions in goodness of fit were seen on
removal of interarm differences in systolic blood pressure from
the models.
Stratified analysis
In primary prevention of cardiovascular disease a 10 year
cardiovascular risk score of more than 20% over 10 years
represents a threshold for intervention with statin therapy.25
Participants without pre-existing cardiovascular disease were
therefore stratified by both their conventional risk score (above
or below the threshold of 20%) and their interarm difference in
systolic blood pressure (above or below 10 mm Hg). Analysis
showed that the presence of an interarm difference in systolic
blood pressure of 10 mm Hg or more without pre-existing
disease, but where the cardiovascular risk score was more than
20%, was associated with a significantly higher hazard of
combined fatal and non-fatal events compared with those with
an interarm difference in systolic blood pressure of less than 10
mm Hg but equivalent cardiovascular risk score (log rank
statistic 25.9, P<0.001) and also a higher hazard when compared
with those with pre-existing disease (log rank statistic 4.5,
P<0.05; fig 5⇓).
Discussion
A difference in systolic blood pressure between arms of 10 mm
Hg or more or 15 mm Hg or more in people with hypertension
in primary care was associated with a reduction in event free
survival over 10 years. This association held for the study
population when participants with pre-existing cardiovascular
disease were included or excluded and, compared with our
earlier analysis at 4.7 years’ follow-up, the survival curves have
continued to diverge. The presence of an interarm difference in
systolic blood pressure of 10 mm Hg or more in participants
not known to have cardiovascular disease at recruitment but
with a high cardiovascular risk score of more than 20% at
baseline, seems to confer a level of risk for events of similar
magnitude to that of participants with previously diagnosed
cardiovascular disease.
Strengths and limitations of the study
One investigator (CEC) gathered all the data. In designing this
study, a sequential method of measurement was chosen as a
pragmatic test within the consultation. A recent meta-analysis
has suggested that a simultaneous, automated repeated
measurement method with one or two machines should be the
ideal for epidemiological study,26 and we also, subsequent to
establishing this study, showed that a simultaneousmeasurement
technique reduces bias.1 Studies relevant to the general
population using such techniques27-31 have reported lower
prevalences of an interarm difference in blood pressure than
those using sequential measurements.2 19 29 32-38 However,
subsequent sampling of the study cohort presented here, using
a robust simultaneous measurement technique, showed similar
prevalence rates for interarm differences of 10 mm Hg or more
of 19% for systolic blood pressure and 7% for diastolic blood
pressure (compared with the 23% and 6% reported here).39 One
study also reported a strong correlation of interarm differences
when comparing three simultaneous and three sequentially
gathered pairs of readings, and a correlation remained when
measurements were repeated at a later date.40We have presented
data suggesting that a single sequential pair of measurements
can reliably rule out an interarm difference in blood pressure
with high negative predictive value,41 and our newmeta-analysis
has shown no difference in the strength of association between
peripheral vascular disease and systolic interarm differences in
blood pressure according to themethod of measurement.42Given
current knowledge, if designing this study nowwe would adopt
an automated simultaneous measurement method, although we
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believe that our pragmatic approach remains relevant to “real
world” practice.43
The lack of strict randomisation of the order of armmeasurement
could have introduced bias, as blood pressure measurements
will often decrease during repetition.11 No strict first arm
preference was adopted, however, and the small absolute
difference in blood pressure in favour of right or left arms is in
keeping with previously reported large series and suggests that
no systematic bias was introduced.19 27 32 44 The investigator CEC
was not blinded to data collection, but because events were
recorded prospectively over 10 years, and our definitions of
non-fatal events required independent diagnosis in secondary
care, we do not believe that this lack of blinding could have
biased the survival outcomes reported. We did not collect data
on drug use at recruitment or changes in use during the study
period, so cannot comment on potential survival differences
due to drugs.
This is a small study from one rural general practice. The
reported prevalence of participants receiving treatment for
hypertension in this study was 14.3% of the list, comparable to
the 13.7% for women and 11.7% for men reported at the time
by the health survey for England.45 Therefore we believe that
these findings can be generalised to other similar cohorts of
people with hypertension being treated in primary care, although
the lack of representation of ethnic minority groups in Devon
is a recognised limitation. Conversely, this rural practice has a
low turnover of patients, facilitating long term follow-up, which
we see as a strength.
Based on the previous analysis of this cohort, giving a hazard
ratio of 2.5 for the composite outcome of mortality or event at
a cut-off point for interarm difference in systolic blood pressure
of 10 mmHg, we estimated that we would have required a total
of 50 observed events to achieve 90% power and 62 to achieve
95% power. In this follow-upwe observed 108 deaths or events.1
Higher cut-off values were initially included in the analysis plan
to permit comparison with other survival studies8 9; however,
the diminishing numbers of participants with an interarm
difference in systolic blood pressure of more than 15 mm Hg
meant a reduced precision of the event results for higher interarm
differences, these analyses are therefore not included in the data
presented.
Comparison with existing literature
Prevalence of an interarm difference in blood pressure varies
with the population studied and tends to be higher in the
presence of hypertension.29 37 46 Whether this reflects a truly
higher prevalence or is merely a function of higher achievement
of an arbitrary cut-off point where absolute values are increased
is unclear, but the prevalence values reported here are consistent
with our previous meta-analysis of similar cohorts measured
with robust techniques.1
Some previous series have suggested a bias towards higher
readings from the right arm,2 31 33 36-38 47 48 whereas others have
failed to show this19 27 32 44 46 49; studies looking specifically at
left or right handedness have also failed to show an association
with the arm producing the higher reading.29 31 This study has
not found a consistent bias to one side for interarm differences
in either systolic or diastolic blood pressures, and shows that
measurement using both arms at initial assessment is required
to avoid future underestimation of blood pressure owing to an
unrecognised difference between arms. In fact the direction of
mean differences in systolic and diastolic blood pressures was
opposite, in keeping with some other reported series, and we
suggest this may be related to differing pulse pressures along
the aorta.31 50 Current guidance suggests that an interarm
difference of less than 10mmHg can be considered to be normal
and that differences of 20/10 mmHg or more warrant specialist
referral.18 51 Previous studies have proposed a normal range for
differences in systolic or diastolic blood pressure of up to 10
mmHg27 and it has been argued from other cross sectional series
that the high prevalence of differences above these cut-off points
implies that this is a physiological rather than a pathological
finding.44 50 Our recent meta-analysis has, however, shown that
an interarm difference in systolic blood pressure of 10 mm Hg
or more or 15 mm Hg or more is associated with peripheral
vascular disease in cross sectional studies, with a pooled risk
ratio of 2.4 or 2.5, respectively.42 Peripheral vascular disease is
recognised as a risk factor for future cardiovascular events and
mortality,52 and we have previously proposed that an interarm
difference in blood pressure is due to peripheral vascular
disease.53 An interarm difference in systolic blood pressure of
15 mmHg or more is associated with angiographic evidence of
carotid or aortic artery disease,54 and vascular disease of the
arms is associated with hypertension.55 Thus evidence supports
the association of an interarm difference with existing peripheral
vascular disease, and we propose that this accounts for the
survival differences seen.
Two other prospective studies have reported increased mortality
with an interarm difference in systolic blood pressure; the larger
study reported a significant survival difference with a difference
of 15 mm Hg or more. Three cohorts were combined in that
paper and differences were not significant for the cohort
recruited from the community; only total deaths were
significantly higher in one of the two cohorts recruited from
vascular clinics.9 The other study, of renal and general medical
out-patients, showed significantly higher rates of events or death
for an interarm difference in systolic blood pressure of 10 mm
Hg or more.8 Meta-analysis to combine data for an interarm
difference in systolic blood pressure of 15 mm Hg or more
presented here with three other cohorts9was possible and showed
pooled hazard ratios for all cause mortality of 1.6 (95%
confidence interval 1.1 to 2.3) and for cardiovascular related
mortality of 1.7 (1.1 to 2.5).42 Thus there is supporting evidence
from other studies that an interarm difference in blood pressure
is a predictor of cardiovascular events and death in populations
at high baseline cardiovascular risk.
Implications for clinical practice
Guidelines advocate the measurement of blood pressure in both
arms as part of the initial assessment of hypertension.11 12 Failure
to recognise a difference can lead to underestimation or
under-treatment of blood pressure, but this guidance is not
routinely followed in primary care13-15 and the additional time
required to measure both arms has been cited as a practical
problem.6 56 It is postulated that this poor uptake may be due in
part to a lack of evidence thought to be relevant by primary care
practitioners,17 and guidelines should make use of available
evidence rather than consensus views where evidence does
exist.42 The finding here of an additional cardiovascular risk
associated with an interarm difference in a representative
primary care cohort with hypertension is therefore important.
In this study, regression modelling showed the interarm
difference to be an independent variable associated with
increased risk of events or death, and in stratified analysis its
presence conferred a risk equivalent to established
cardiovascular disease. This would suggest that those with an
interarm difference may justifiably require aggressive
management along secondary prevention guidelines, such as
the addition of statin therapy, and potentially by adding
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antiplatelet treatment to their care; a strategy that remains of
unclear benefit in primary cardiovascular prevention.57 This
seems a logical and pathologically plausible proposal since such
treatment is effective in secondary prevention and therefore
ought to be effective in primary prevention for selected cases
at the highest vascular risk; however, further work is needed to
justify this approach. We have suggested that the interarm
difference is a manifestation of occult peripheral vascular
disease,53 which is known to confer an increased risk of events
or death58 59 and is therefore managed with aggressive lifestyle
and drug strategies. Non-invasive studies have repeatedly shown
an association of interarm differences in systolic blood pressure
of 10 mmHg or more5 6 39 49 60 and 15 mmHg or more5 6 39 49 54 61-63
with peripheral vascular disease, and we consider that
confirmation of an interarm difference may indicate that further
assessment for the presence of peripheral vascular disease should
be undertaken.42 To date, however, there are no studies of
relevant interventions on which to base clinical
recommendations.
Implications for future research
This study adds important information to the evidence base
supporting the need to detect an interarm difference in blood
pressure, not only to improve measurement and management
of hypertension but to consider the vascular risk to the patient.
The interarm difference in blood pressure has the potential to
act as a simple non-invasive test, identifying those who could
benefit from more intensive assessment—for example, by
measurement of ankle-brachial pressure index. This
measurement is not routinely undertaken in the primary care
assessment of patients with hypertension and is not included in
the NHS health check programme.64 It requires time, experience,
and training,65 whereas bilateral brachial blood pressure
measurements can be easily taken. Therefore, further studies of
the association of interarm differences in blood pressure with
other manifestations of peripheral and cardiovascular disease,
in cohorts representative of the primary care population, would
be valuable.
Conclusions
An interarm difference in systolic blood pressure of 10 mm Hg
or more or 15 mm Hg or more predicts reduced mortality and
event free survival over 10 years in people with hypertension
in primary care. This study supports the potential value of an
interarm difference as a simple clinical indicator of increased
cardiovascular risk. Assessment of blood pressure in both arms
is recommended by guidelines and should become a core
component of initial blood pressure measurement in primary
care. Detection of an interarm difference should prompt
consideration of further vascular assessment and aggressive
management of risk factors.
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Tables
Table 1| Characteristics of people included and excluded from analyses. Values are numbers (percentages) unless stated otherwise
P value
Framingham score
Characteristics Incomplete data (n=17)Full data (n=230)
Continuous variables
<0.001*79.2 (9.8)68.1 (9.6)Mean (SD) age (years)
0.26*26.9 (3.0)27.9 (4.4)Mean (SD) body mass index
Mean baseline blood pressure (mm Hg):
0.37*165.8 (23.4)160.5 (17.0)Mean (SD) systolic
0.13*89.5 (8.6)86.1 (8.6)Mean (SD) diastolic
Dichotomous variables
0.17†5 (29)107 (47)Men
0.62‡0 (0)18 (8)Diabetes
0.76‡4 (24)47 (20)Pre-existing ischaemic heart disease or peripheral vascular disease
0.72‡4 (18)32 (14)Smoker
0.40‡6 (35)59 (26)Deaths (all causes)
1.00†7 (41)100 (44)Events or deaths
*t test.
†χ2 test.
‡Fisher’s exact test.
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Table 2| Comparison of baseline variables and outcomemeasures for interarm differences in systolic blood pressure and in diastolic blood
pressure. Values are numbers (percentages) unless stated otherwise
Interarm difference in diastolic blood pressure (mm
Hg)Interarm difference in systolic blood pressure (mm Hg)
Variables P value≥10 (n=14)<10 (n=216)P value≥15 (n=21)<15 (n=209)P value≥10 (n=55)<10 (n=175)
Continuous variables
0.49*66.8 (7.2)68.2 (9.7)0.28*70.7 (11.5)67.9 (9.4)0.16*69.7 (10.1)67.6 (9.4)Mean (SD) age (years)
0.23*26.9 (2.7)27.9 (4.5)0.60*27.4 (4.2)27.9 (4.4)0.23*27.3 (3.6)28.0 (4.6)Mean (SD) body mass
index
Mean baseline blood
pressure (mm Hg):
0.28*167.1 (23.1)160.1 (16.5)0.44*163.3 (19.2)160.2 (16.8)0.51*161.8 (16.3)160.1 (17.2)Systolic blood pressure
0.17*90.6 (12.0)85.8 (8.3)0.98*86.1 (6.0)86.1 (8.8)0.99*86.1 (8.2)86.1 (8.7)Diastolic blood pressure
0.75*24.7 (11.9)25.8 (12.1)0.31*28.4 (12.1)25.5 (12.1)0.058*28.4 (11.7)24.9 (12.1)Framingham 10 year risk
score (%)
Dichotomous variables
0.79†7 (50)100 (46)0.72†9 (43)98 (47)0.90†26 (47)81 (46)Male
0.61‡0 (0)18 (8)1.00‡1 (5)17 (8)0.39‡6 (11)12 (7)Diabetes
1.00‡1 (3)28 (13)0.49‡1 (5)28 (13)0.17†4 (7)25 (14)Angina
0.33‡2 (14)17 (8)0.23‡0 (0)19 (9)0.26‡2 (4)17 (10)Myocardial infarction
0.53†0 (0)17 (8)0.43†3 (14)14 (7)0.73†5 (9)12 (7)Cerebrovascular disease
0.27‡1 (7)4 (2)1.00‡0 (0)5 (2)0.34‡0 (0)5 (3)Peripheral vascular
disease
1.00‡2 (14)30 (14)0.51‡4 (19)28 (13)0.55†9 (16)23 (13)Smoker
*t test.
†χ2 test.
‡Fisher’s exact test.
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Table 3| Unadjusted and adjusted hazard ratios at predefined cut-off levels of interarm differences in blood pressure (n=230)
P value§Adjusted hazard ratio model 2‡P value†
Adjusted hazard ratio
model 1*Unadjusted hazard ratioInterarm differences
Combined cardiovascular and cerebrovascular events
Systolic blood pressure cut-off:
<0.0012.8 (1.7 to 4.6)0.0012.2 (1.4 to 3.6)2.5 (1.6 to 4.0)10 mm Hg
0.0052.8 (1.5 to 5.4)0.0242.2 (1.2 to 4.2)2.5 (1.3 to 4.6)15 mm Hg
Diastolic blood pressure cut-off:
0.0043.8 (1.7 to 8.4)0.0462.3 (1.1 to 4.8)2.3 (1.1 to 4.7)10 mm Hg
Cardiovascular deaths
Systolic blood pressure cut-off:
0.0024.2 (1.7 to 10.3)0.0072.9 (1.4 to 6.0)3.4 (1.7 to 7.2)10 mm Hg
0.0852.7 (1.0 to 7.7)0.2511.8 (0.7 to 4.9)2.4 (0.91 to 6.3)15 mm Hg
Diastolic blood pressure cut-off:
0.1942.5 (0.7 to 9.2)0.3122.0 (0.6 to 6.5)1.7 (0.5 to 5.5)10 mm Hg
All deaths
Systolic blood pressure cut-off:
<0.0013.6 (2.0 to 6.5)<0.0013.0 (1.8 to 5.0)3.4 (2.0 to 5.7)10 mm Hg
0.0033.1 (1.6 to 6.0)0.0112.5 (1.3 to 4.7)3.0 (1.6 to 5.6)15 mm Hg
Diastolic blood pressure cut-off:
0.8401.1 (0.3 to 3.7)0.8200.9 (0.3 to 2.8)0.8 (0.2 to 2.5)10 mm Hg
Non-fatal events or deaths
Systolic blood pressure cut-off:
<0.0012.8 (1.8 to 4.3)<0.0012.4 (1.6 to 3.6)2.7 (1.8 to 4.0)10 mm Hg
0.0012.8 (1.6 to 4.9)0.0062.3 (1.3 to 4.0)2.6 (1.5 to 4.4)15 mm Hg
Diastolic blood pressure cut-off:
0.0053.3 (1.6 to 6.8)0.0811.9 (1.0 to 3.9)1.9 (1.0 to 3.9)10 mm Hg
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio test from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure, presence of diabetes, and pre-existing vascular disease.
§P value for likelihood ratio test from omission of interarm differences from multivariable model 2.
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Table 4| Unadjusted and adjusted hazard ratios for absolute interarm differences in systolic and diastolic blood pressure (risk per mm Hg
difference)
P value§
Adjusted hazard ratio
model 2‡P value†
Adjusted hazard ratio
model 1*Unadjusted hazard ratioInterarm differences
All cases
Systolic blood pressure:
<0.0011.05 (1.03 to 1.08)0.0021.04 (1.02 to 1.07)1.06 (1.03 to 1.08)All events and deaths
0.0011.06 (1.03 to 1.09)0.0031.04 (1.02 to 1.07)1.06 (1.03 to 1.08)All deaths
0.0501.05 (1.01 to 1.10)0.1451.03 (0.99 to 1.07)1.05 (1.01 to 1.09)Cardiovascular deaths
Diastolic blood pressure:
0.0241.09 (1.01 to 1.16)0.1921.05 (0.98 to 1.12)1.05 (0.98 to 1.12)All events and deaths
0.4601.04 (0.95 to 1.13)0.9101.01 (0.92 to 1.10)1.00 (0.92 to 1.09)All deaths
0.6001.04 (0.91 to 1.18)0.9341.00 (0.88 to 1.13)1.00 (0.88 to 1.12)Cardiovascular deaths
No pre-existing cardiovascular disease
Systolic blood pressure:
0.0011.05 (1.02 to 1.08)0.0011.05 (1.02 to 1.08)1.06 (1.04 to 1.09)All events and deaths
0.0081.05 (1.02 to 1.08)0.0201.04 (1.01 to 1.06)1.06 (1.03 to 1.08)All deaths
0.1151.05 (1.00 to 1.10)0.1791.03 (0.99 to 1.07)1.06 (1.02 to 1.10)Cardiovascular deaths
Diastolic blood pressure:
0.1431.06 (0.98 to 1.15)0.5031.03 (0.95 to 1.11)1.03 (0.95 to 1.10)All events and deaths
0.7701.02 (0.91 to 1.14)0.6800.98 (0.88 to 1.09)0.97 (0.88 to 1.07)All deaths
0.9971.00 (0.85 to 1.18)0.8120.98 (0.84 to 1.15)0.97 (0.84 to 1.13)Cardiovascular deaths
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio test from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure, presence of diabetes, and pre-existing vascular disease (for all cases analyses).
§P value for likelihood ratio test from omission of interarm differences from multivariable model 2.
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Table 5| Unadjusted and adjusted hazard ratios at predefined levels of interarm differences in blood pressure in participants without
pre-existing vascular disease (n=183)
P value§Adjusted hazard ratiomodel 2‡P value†Adjusted hazard ratio model 1*Unadjusted hazard ratioInterarm difference
Combined cardiovascular and cerebrovascular events
Systolic blood pressure cut-off:
<0.0013.0 (1.7 to 5.3)<0.0013.1 (1.8 to 5.5)3.5 (2.1 to 6.1)10 mm Hg
0.0023.2 (1.6 to 6.4)0.0052.9 (1.5 to 5.5)3.3 (1.7 to 6.3)15 mm Hg
Diastolic blood pressure cut-off:
0.0323.2 (1.2 to 7.9)0.1292.1 (0.9 to 4.8)2.1 (0.9 to 4.9)10 mm Hg
Cardiovascular deaths
Systolic blood pressure cut-off:
0.0073.7 (1.4 to 9.9)0.0024.2 (1.7 to 10.8)5.5 (2.2 to 13.8)10 mm Hg
0.0792.8 (1.0 to 8.3)0.1702.2 (0.8 to 6.0)3.1 (1.1 to 8.5)15 mm Hg
Diastolic blood pressure cut-off:
0.4182.1 (0.4 to 11.0)0.4521.8 (0.4 to 8.0)1.6 (0.4 to 6.8)10 mm Hg
All deaths
Systolic blood pressure cut-off:
0.0022.6 (1.4 to 4.8)0.0012.8 (1.5 to 5.0)3.4 (1.9 to 6.1)10 mm Hg
0.0122.7 (1.3 to 5.4)0.0262.3 (1.2 to 4.6)3.0 (1.5 to 6.0)15 mm Hg
Diastolic blood pressure cut-off:
0.8911.1 (0.3 to 4.8)0.6790.8 (0.2 to 3.1)0.7 (0.2 to 2.7)10 mm Hg
Events or deaths
Systolic blood pressure cut-off:
<0.0012.7 (1.7 to 4.4)<0.0012.8 (1.8 to 4.5)3.2 (2.0 to 5.0)10 mm Hg
0.0022.8 (1.6 to 5.1)0.0032.6 (1.5 to 4.6)2.8 (1.7 to 5.3)15 mm Hg
Diastolic blood pressure cut-off:
0.0802.4 (1.0 to 5.9)0.4011.5 (0.6 to 3.4)1.5 (0.6 to 3.4)10 mm Hg
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio testing from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure and presence of diabetes.
§P value for likelihood ratio testing from omission of interarm differences from multivariable model 2.
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Figures
Fig 1 Flow of participants through study
Fig 2 Distribution of interarm difference (mean of right arm minus mean of left arm) in systolic blood pressure (SBP) in
study sample of 230 people with hypertension
Fig 3 Kaplan-Meier plot for all cause mortality in 230 people with hypertension with or without an interarm difference in
systolic blood pressure (SBP) of ≥10 mm Hg
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Fig 4 Kaplan-Meier plot for all cause mortality in 183 people with hypertension without cardiovascular disease at recruitment,
with or without an interarm difference in systolic blood pressure (SBP) of ≥10 mm Hg
Fig 5 Kaplan-Meier survival curve for fatal and non-fatal events stratified by pre-existing cardiovascular disease (CVD) at
recruitment, cardiovascular risk score, and interarm difference in systolic blood pressure (SBP) ≥10 mm Hg (n=230)
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